Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2016
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 03 Oct 2016 Status changed from active, no longer recruiting to completed.
- 04 Nov 2014 Planned End Date changed from 1 Jun 2013 to 1 Sep 2016, as reported by ClinicalTrials.gov record.
- 04 Nov 2014 Planned primary completion date changed from 1 Jun 2013 to 1 Sep 2016, as reported by ClinicalTrials.gov record.